1,066 results on '"Monfardini, S"'
Search Results
2. Interventional oncology in the elderly: Complications and early response in liver and kidney malignancies
3. The Older Patients and the Epidemiological Change after COVID-19 Pandemic. The Simplicity of the Complexity Management and the Personalization in Cancer Care
4. Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper
5. Escalating doses of Epirubicin in combination with Ifosfamide and GM-CSF in previously untreated soft tissue sarcoma patients; a phase I–II study
6. Preoperative versus postoperative docetaxel–cisplatin–fluorouracil (TCF) chemotherapy in locally advanced resectable gastric carcinoma: 10-year follow-up of the SAKK 43/99 phase III trial†
7. EORTC elderly task force position paper: Approach to the older cancer patient
8. Expression of myelomonocytic antigens is associated with unfavourable clinicoprognostic factors in B-cell chronic lymphocytic leukaemia
9. Non-Hodgkin’s Lymphomas in Patients with AIDS
10. Conclusions
11. Pathological Assessment of the Results of Intra-arterial Chemotherapy for Head and Neck Carcinomas by Serial Sections of the Whole Specimen
12. Organisation de l’activité clinique en oncologie gériatrique: propositions de la SIOG (Société internationale d’oncologie gériatrique)
13. Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer
14. Which benefit from adding gemcitabine to vinorelbine in elderly (≥70 years) women with metastatic breast cancer? Early interruption of a phase II study
15. Bringing geriatrics into oncology or also oncology into geriatrics?
16. Adjuvant chemotherapy for elderly patients (≥70 years) with early high-risk breast cancer: a retrospective analysis of 260 patients
17. Vinorelbine and prednisone in frail elderly patients with intermediate-high grade non-Hodgkin's lymphomas
18. A phase I–II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer
19. Older cancer patients in an Italian hospice
20. Medical approach to advanced prostate cancer in older patients
21. Treatment of advanced breast cancer in elderly women: medical approach
22. Cancer treatment in the elderly: the need for a better organization
23. Management of the elderly cancer patients complexity: The radiation oncology potential
24. RFS2000 (9-nitrocamptothecin) in advanced small cell lung cancer, a phase II study of the EORTC New Drug Development Group
25. Multidimensional geriatric evaluation in elderly cancer patients: a practical approach
26. Evaluation of renal function in elderly cancer patients
27. Can the ISO9000 quality assessment be applied to the practice of medical oncology?
28. Carboplatin and teniposide as third-line chemotherapy in patients with recurrent oligodendroglioma or oligoastrocytoma: a phase II study
29. A PANEL OF SERUM MARKERS FOR BREAST AND OVARIAN CANCER
30. A SYSTEMATIC REVIEW ON GRAFT VERSUS TUMOR (GVT) EFFECT IN SOLID TUMORS
31. TREATMENT OF FRAIL ELDERLY PATIENTS (PTS) WITH NONHODGKINʼS LYMPHOMA (NHL) WITH VINORELBINE (VNR) AND PREDNISONE (PDN)
32. GEMCITABINE (GEM) AS SALVAGE TREATMENT IN PATIENTS (PTS) WITH ADVANCED COLORECTAL CANCER (CRC) PROGRESSING AFTER TREATMENT WITH 5-FLUOROURACIL (FU), IRINOTECAN (IRI) AND OXALIPLATIN (OXA)
33. INCLUSION IN PHASE II TRIALS IMPROVES SURVIVAL OF ELDERLY PATIENTS (EP) WITH METASTATIC COLORECTAL CANCER (MCRC)
34. PHASE II TRIAL OF DOCETAXEL (D), CISPLATIN (C) AND FLUOROURACIL (F), FOLLOWED BY RADIOTHERAPY (XRT) AND CARBOPLATIN (CBDCA) IN PATIENTS (PTS) WITH UNRESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
35. EPIRUBICIN AND DOCETAXEL AS NEO-ADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED BREAST CANCER: RESULTS OF A RETROSPECTIVE STUDY
36. Phase II trials with flavone acetic acid (NCS. 347512, LM975) in patients with advanced carcinoma of the breast, colon, head and neck and melanoma
37. Thymidylate synthase protein expression in colorectal cancer metastases predicts for clinical outcome to leucovorin-modulated bolus or infusional 5-fluorouracil but not methotrexate-modulated bolus 5-fluorouracil
38. Phase-II-Studie zur Behandlung des fortgeschrittenen Kolorektalkarzinoms (CRC) mittels Dauerinfusion von 5-Fluorouracil (5-FU) plus CPT-11, alternierend mit Dauerinfusion von 5-FU plus Oxaliplatin (L-OHP): Hohe Aktivität bei geringer Toxizität: 2212
39. Phase II Study of Sequential Administration of Docetaxel Followed by Doxorubicin and Cyclophosphamide as First-Line Chemotherapy in Metastatic Breast Cancer
40. Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: A phase II study
41. LONG-TERM RESULTS IN PATIENTS (PTS) WITH RESPONSIVE LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS (LADSCCE), TREATED WITH CHEMO-RADIOTHERAPY (CT-RT) FOLLOWED BY SURGERY (S)
42. Carboplatin plus vinorelbine in head and neck or oesophageal carcinoma in the elderly or in patients with poor performance status (P.S.): Preliminary report.
43. Thymidylate synthase protein expression in colorectalcancer metastases predicts for clinical outcome to leucovorin-modulated bolus or infusional 5-fluorouracil but not methotrexate-modulated bolus 5-fluorouracil
44. Thymidylate Synthase expression as a predictor of clinical response to fluoropyrimidine-based chemotherapy in advanced colorectal cancer
45. Management of small-cell lung cancer in the elderly
46. Childhood Acute Lymphocytic Leukaemia
47. Childhood Brain Tumours
48. Paediatric Non-Hodgkin Lymphomas
49. Rhabdomyosarcomas
50. Acute Leukaemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.